# FDA Inspection 1217513 - New York Blood Center Enterprises - September 07, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/47b41b89-58c5-4997-8124-42cebc55bddf
Source feed: FDA_Inspections

> FDA Inspection 1217513 for New York Blood Center Enterprises on September 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217513
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2023-09-07
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1283668 - 2025-09-24](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/91ecba89-ae8a-4854-a2eb-f3ceac565d66)
- [FDA Inspection 1217513 - 2023-09-07](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/c705a6ed-1f5c-44af-afd1-f42b0bc46779)
- [FDA Inspection 1118178 - 2020-02-11](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/d7c05152-a755-44b7-acb6-8b9840cbb679)
- [FDA Inspection 1036848 - 2017-11-22](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/c5d0fa69-163e-462a-83c2-e34a55cd287b)
- [FDA Inspection 1027270 - 2017-09-29](https://www.globalkeysolutions.net/records/fda_inspections/new-york-blood-center-enterprises/019b559d-7299-43c7-bebb-75f4f7aae907)

Company: https://www.globalkeysolutions.net/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d